Answer
Yes, co-administration of dabigatran etexilate, a P-glycoprotein substrate, with Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead is contraindicated.
Sources for this answer
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead 150mg/150mg/200mg/10mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.3 Contraindications · Version 37Document updated
Sources checked